Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-10gcjj55Phase 3Recruiting
Phase 3, open-label trial of amoxicillin in surgical site infection (SSI) (3 arms), sponsored by Faculdade de Odontologia da Universidade Federal de Uberlândia. Primary endpoint: Occurrence of extraction-site infection. Started Jul 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-10gcjj55.